Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Dec 12, 2020 10:19pm
178 Views
Post# 32094635

Lucrative Billion $$$ market -TESTING with Recurring Revenue

Lucrative Billion $$$ market -TESTING with Recurring RevenueDid you know that there was in the USA 198 million flu vaccine shots that are given every year?

Did you know that there are millions of blood tests done to check for a large host of medical issues?

Did you know that the present antibody and antigen will not go away for years as people will fear a return of the covid19 virus or another deadly virus.   Testing will become industry practice. 

QSC can work with medical establishments or hospitals as these are overloaded and can take up a huge chunk to the testing work, done efficiently, quickly and without overburdening the system. 

QSC is establishing a template in executing its business model that will become an INVALUABLE SERVICE to the medical industry. 

Our CEO Doug Sommerville is a TRUE VISIONARY.

How many venture companies can boast doing over 1/2 billion in revenue in 2021 with a 55% bottom line. 

Find me one????

MPO




<< Previous
Bullboard Posts
Next >>